Medicine
Methylphenidate 5 mg/5 mL oral solution
Methylphenidate 5 mg/5 mL oral solution is a generic prescription medicine for oral use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), with excursions permitted between 15° to…
Key facts
- Active ingredient (INN)
- Methylphenidate
- Brand
- Sold under the generic name
- Strength
- 5 mg/5 mL
- Dosage form
- Oral solution
- Route
- Oral
- Packs
- 500 mL, 250 mL and 9 more
- Manufacturers
- Ascend LaboratoriesIndiaLupinIndiaBryant Ranch PrepackAscent PharmaceuticalsCranbury PharmaceuticalsEywa PharmaKVK-TechPatrin PharmaQuagen Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), with excursions permitted between 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CII
- ATC code
- N06BA04 Methylphenidate
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 4 March 2015
- Identifiers
- RxCUI 1091133, 1091341DailyMed set ID 2cf1b26b-199d-4c7f-ab64-4805a9def2cc, b9c31526-d486-433c-9b3c-7a12765afe94, e817377f-bc72-415a-acd2-7136746b2479 +8NDC 10702-163, 72162-1992, 27808-058 +8Application ANDA207485, ANDA210139, ANDA091601 +5
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 500 mL in 1 bottle | 67877-602-91 | Ascend LaboratoriesIndia | 1 April 2020 |
| 500 mL in 1 bottle | 43386-930-05 | LupinIndia | 15 December 2015 |
| 500 mL in 1 bottle | 43602-177-05 | Ascent Pharmaceuticals | 29 January 2021 |
| 250 mL in 1 bottle | 43602-177-25 | Ascent Pharmaceuticals | 29 January 2021 |
| 500 mL in 1 bottle, plastic | 27808-058-01 | Cranbury Pharmaceuticals | 4 March 2015 |
| 500 mL in 1 bottle | 71930-024-52 | Eywa Pharma | 29 March 2019 |
| 500 mL in 1 bottle | 10702-163-50 | KVK-Tech | 23 January 2017 |
| 500 mL in 1 bottle | 39328-054-50 | Patrin Pharma | 23 April 2020 |
| 500 mL in 1 bottle, plastic | 70752-131-14 | Quagen Pharmaceuticals | 4 June 2020 |
| 500 mL in 1 bottle | 63629-1175-1 | Bryant Ranch Prepack | 26 July 2022 |
| 500 mL in 1 bottle | 72162-1992-5 | Bryant Ranch Prepack | 3 April 2024 |
| 500 mL in 1 bottle, plastic | 72162-2040-5 | Bryant Ranch Prepack | 3 April 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Methylphenidate 5 mg/5 mL oral solution.
Other strengths and forms of Methylphenidate
Clinical summary
Methylphenidate is a central nervous system stimulant indicated for the treatment of attention Deficit Hyperactivity Disorders (ADHD) in pediatric patients 6 years and older and adults, among other approved uses. MedsAcross supplies Methylphenidate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MethylphenidateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Ritalin prescribing information (Sandoz) · U.S. National Library of Medicine, DailyMed
- Tuzulby: European public assessment report (EPAR) · European Medicines Agency
Need Methylphenidate 5 mg/5 mL oral solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.